Efficient cell line development remains one of the most critical challenges in biotherapeutic manufacturing. Achieving stable ...

When pathogens enter our cells as part of an infection, our body will trigger a programmed cell death known as "pyroptosis" ...

Research on human brain organoids (HBOs) is directly challenging how biobanks and biomedical institutes recruit volunteers.

This study provides fundamental information on how Arg-II participates in cardiac aging. The phenotypic data provide convincing evidence of non-cell-autonomous contributions to aging-related ...

Every cell in the body has the same DNA, but different cell types—such as muscle or brain cells—use different parts of it.

Tiragolumab plus atezolizumab does not improve survival compared to durvalumab in locally advanced, unresectable, stage 3 NSCLC.

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Researchers have discovered that free radicals generated at a specific site in non-neuronal brain cells called astrocytes, ...

Combination therapy with cadonilimab, a first-in-class bispecific antibody targeting both PD-1 and CTLA-4, and chemotherapy offers encouraging antitumor activity and manageable safety as a first-line ...

These days, phone scammers are getting more and more creative. In some states like California, their schemes are even starting to involve law enforcement.

Lecturer Barri Brennan, on paid leave since her comments were posted on social media, is scheduled to return in the spring.

The study will test the antibody-drug conjugate in combination with Keytruda in patients with HER2-overexpressing metastatic non-small cell lung cancer.